PINX: EMOR
Morningstar‘s Stock Analysis EMOR
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
About Quantitative Ratings
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Unlock Our Full Analysis With Morningstar Investor
Company Profile EMOR
Business Description
Healixa Inc is a digital healthcare ecosystem. The company is engaged in the creation, acquisition, development, and deployment of ethically engineered healing technologies. It serves a broad range of industries including employer telehealth, benefits, travel, pharmacy, logistics, and others. The Company also focuses on clean water through its Global AquaDuct™ atmospheric water harvesting technology, It also owns and operates patient care coordination software and services.
Competitors & Peers EMOR
Morningstar does not cover competitors or peers for this firm.
FAQs for Healixa Inc Stock
No. EMOR does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
EMOR’s market cap is 196.29 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
EMOR’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare EMOR’s historical performance against its industry peers and the overall market.